TMO (US)


February 8, 2025

Life Science Tools: NIH Indirect Cost Cut Risks

By John Leppard

NIH’s surprise announcement Friday of a 15% cap on indirect costs for both new and existing grants will likely trigger fresh uncertainty for life science tools (LST) manufacturers. While indirect costs are technically distinct from…

Read More >>

December 3, 2024

Life Science Tools: NIH Cuts in Context

By John Leppard

With the life science tools (LST) space still trailing broader market moves following the Nov. 5 election, in part due to investor concerns over NIH funding, we continue to believe that significant budget cuts are…

Read More >>